Skip to main content

Medical Comorbidities

  • Chapter
  • First Online:
  • 1416 Accesses

Abstract

 .

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Black DW. Mortality in schizophrenia – the Iowa record-linkage study: a comparison with general population mortality. Psychosomatics. 1988;29:55–60.

    Google Scholar 

  2. De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10:52–77.

    Google Scholar 

  3. Inder WJ, Castle D. Antipsychotic-induced hyperprolactinaemia. Aust N Z J Psychiatry. 2011; 45:830–837.

    Google Scholar 

  4. Bushe CJ, Bradley A, Pendlebury J. A review of hyperprolactinaemia and severe mental illness: are there implications for clinical biochemistry? Ann Clin Biochem. 2010; 47:292–300.

    Google Scholar 

  5. Graham SM, Howgate D, Anderson W, et al. Risk of osteoporosis and fracture incidence in patients on antipsychotic medication. Expert Opin Drug Saf. 2011;10: 575–602.

    Google Scholar 

  6. Lord O, Malone D, Mitchell AJ. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. Gen Hosp Psychiatry. 2010;32:519–543.

    Google Scholar 

  7. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10:138–151.

    Google Scholar 

  8. Centers for Disease Control and Prevention. Human papillomavirus (HPV). Available at: www.cdc.gov/std/hpv. Accessed April 2, 2012.

  9. US Preventive Services Task Force. Screening for chlamydial infection. Available at: www.uspreventiveservicestaskforce.org/uspstf/uspschlm.htm. Accessed April 2, 2012.

  10. Seeman MV, Ross R. Prescribing contraceptives for women with schizophrenia. J Psychiatr Pract. 2011;17:258–269.

    Google Scholar 

  11. Tilbrook D, Polsky J, Lofters A. Are women with psychosis receiving adequate cervical cancer screening? Can Fam Physician. 2010;56:358–363.

    Google Scholar 

  12. Mayo Clinic. Mammogram. Available at: www.mayoclinic.com/health/mammogram-guidelines/AN02052. Accessed April 2, 2012.

  13. Beckman TJ, Litin SC. Clinical pearls in men’s health. Mayo Clin Proc. 2010;85:668–673.

    Google Scholar 

  14. Izawa JI, Klotz L, Siemens DR, et al. Prostate cancer screening: Canadian guidelines 2011. Can Urol Assoc J. 2011;5:235–240.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Healthcare, a part of Springer Science+Business Media

About this chapter

Cite this chapter

McEvoy, J.P. (2012). Medical Comorbidities. In: Keefe, R. (eds) Guide to Assessment Scales in Schizophrenia. Springer Healthcare, Heidelberg. https://doi.org/10.1007/978-1-908517-71-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-908517-71-5_10

  • Published:

  • Publisher Name: Springer Healthcare, Heidelberg

  • Print ISBN: 978-1-908517-52-4

  • Online ISBN: 978-1-908517-71-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics